Growth Metrics

RxSight (RXST) EBITDA Margin Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -343.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -178.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -283.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 72.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,505.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -184.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -3,846.00
10 RxSight 215.82 Mn -2.06 Mn 23.50 Mn 2,325.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,325.00
Dec 31, 2025 6,867.00
Sep 30, 2025 10,119.00
Jun 30, 2025 11,261.00
Mar 31, 2025 17,564.00
Dec 31, 2024 17,119.00
Sep 30, 2024 20,303.00
Jun 30, 2024 25,766.00
Mar 31, 2024 16,424.00
Dec 31, 2023 24,726.00
Sep 30, 2023 -79,081.00
Jun 30, 2023 41,344.00